Enhanced proliferation and differentiation of human articular chondrocytes when seeded at low cell densities in alginate in vitro.
Dedifferentiated human articular chondrocytes exhibited a wide variation in their capacity to proliferate and redifferentiate in an alginate suspension culture system. The greatest extent of proliferation and redifferentiation was seen to be dependent on the formation of clonal populations of chondrocytes and correlated inversely with the initial cell seeding density. Redifferentiating chondrocytes seeded at low density (1 x 10(4) cells/ml alginate) compared with chondrocytes that were seeded at high density (1 x 10(6) cells/ml alginate) showed a nearly 3-fold higher median increase in cell number. a 19-fold greater level of type-II collagen mRNA expression, a 4-fold greater level of aggrecan mRNA expression, and a 6-fold greater level of sulfated glycosaminoglycan deposition at 4 weeks of culture. Matrix molecules from low-density cultures were assembled into chondrocyte-encapsulated, spherical extracellular matrices that were readily visualized in sections from 12-week cultures stained with antibodies against types I and II collagen and aggrecan. Ultrastructural analysis of 12-week low-density cultures confirmed the presence of thin collagen fibrils throughout the matrix.
Gagne
T A
TA
Genzyme Corporation, Framingham, Massachusetts, USA.
Chappell-Afonso
K
K
Johnson
J L
JL
McPherson
J M
JM
Oldham
C A
CA
Tubo
R A
RA
Vaccaro
C
C
Vasios
G W
GW
D000328:Adult; D053674:Aggrecans; D000464:Alginates / Q000494:pharmacology*; D002358:Cartilage, Articular / Q000187:drug effects* / Q000254:growth & development / Q000648:ultrastructure; D018929:Cell Culture Techniques; D002454:Cell Differentiation / Q000187:drug effects* / Q000502:physiology; D002455:Cell Division / Q000187:drug effects* / Q000502:physiology; D019902:Chondrocytes / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D003094:Collagen / Q000235:genetics / Q000378:metabolism; D003470:Culture Media / Q000494:pharmacology*; D005109:Extracellular Matrix / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D016326:Extracellular Matrix Proteins; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000502:physiology; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D037181:Lectins, C-Type; D008297:Male; D008875:Middle Aged; D011509:Proteoglycans / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D013431:Sulfates / Q000378:metabolism
D053674:Aggrecans; D000464:Alginates; D003470:Culture Media; D016326:Extracellular Matrix Proteins; D006025:Glycosaminoglycans; D037181:Lectins, C-Type; D011509:Proteoglycans; D012333:RNA, Messenger; D013431:Sulfates; D003094:Collagen